Abstract

In recent years, cancer immunotherapy has emerged as a promising approach for treating various malignancies. Among the diverse strategies within this field, targeting immune checkpoints has gained significant attention due to its ability to unleash the body's immune system against tumor cells. This mini-review highlights the recent advancements in immune checkpoint inhibitors and novel strategies in cancer immunotherapy.